Tag: Therapeutics
Turn Therapeutics Refines GX-03 Eczema Trial After Interim Data, Eyes 2026 Readout – MarketBeat
eczemarelief
July 12, 2026
Here's Why Nektar Therapeutics Stock Rocketed 90.6% Higher in September – The Globe and Mail
eczemarelief
October 5, 2025
Available Therapeutics and Upcoming Advancements in Atopic Dermatitis and Prurigo Nodularis – Dermatology Times
eczemarelief
October 26, 2024
Eczema Therapeutics Market: Share, Size, CAGR, Growth,
eczemarelief
September 3, 2022